|
US3048526A
(en)
|
1958-08-04 |
1962-08-07 |
Wander Company |
Medicinal tablet
|
|
GB972128A
(en)
|
1960-01-21 |
1964-10-07 |
Wellcome Found |
Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets
|
|
US3125491A
(en)
|
1962-04-06 |
1964-03-17 |
|
Chew able hematinic vitamin tablet |
|
FR1603314A
(en)
|
1965-02-23 |
1971-04-05 |
|
Pharmaceutical tablets - having a core and a matrix material
|
|
US3870790A
(en)
|
1970-01-22 |
1975-03-11 |
Forest Laboratories |
Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
|
|
FR2100858B1
(sr)
|
1970-07-03 |
1975-06-06 |
Daiichi Seiyaku Co |
|
|
DE2445971A1
(de)
|
1974-09-24 |
1976-04-08 |
Schering Ag |
Arzneimittelwirkstofftraeger ii
|
|
US4797288A
(en)
|
1984-10-05 |
1989-01-10 |
Warner-Lambert Company |
Novel drug delivery system
|
|
GB8518301D0
(en)
|
1985-07-19 |
1985-08-29 |
Fujisawa Pharmaceutical Co |
Hydrodynamically explosive systems
|
|
US5519057A
(en)
|
1986-11-14 |
1996-05-21 |
Johnson & Johnson--Merck Pharmaceuticals Co. |
Ibuprofen-containing medicament
|
|
IT1201136B
(it)
|
1987-01-13 |
1989-01-27 |
Resa Farma |
Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
|
|
GB8705083D0
(en)
|
1987-03-04 |
1987-04-08 |
Euro Celtique Sa |
Spheroids
|
|
GB8820353D0
(en)
|
1988-08-26 |
1988-09-28 |
Staniforth J N |
Controlled release tablet
|
|
US5047246A
(en)
|
1988-09-09 |
1991-09-10 |
Bristol-Myers Company |
Direct compression cyclophosphamide tablet
|
|
IT1230576B
(it)
|
1988-10-20 |
1991-10-28 |
Angeli Inst Spa |
Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
|
|
US4966770A
(en)
|
1989-07-26 |
1990-10-30 |
Himedics, Inc. |
Prednisone microencapsulated granules
|
|
DE3930770A1
(de)
|
1989-09-14 |
1991-03-28 |
Wolfgang F Dr Schoener |
Implantierbare katheter aus medizinisch vertraeglichem elastischen kunststoff
|
|
IT1246382B
(it)
|
1990-04-17 |
1994-11-18 |
Eurand Int |
Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
|
|
JP2558396B2
(ja)
|
1990-06-28 |
1996-11-27 |
田辺製薬株式会社 |
放出制御型製剤
|
|
CA2085231C
(en)
|
1990-07-02 |
1997-12-30 |
Berthold Stemmle |
Process for the preparation of shaped, compressed controlled-release unit-dosage forms, and the compressed unit-dosage forms thus obtained
|
|
JP2521848B2
(ja)
|
1990-07-02 |
1996-08-07 |
ベーリンガー マンハイム ゲーエムベーハー |
成形され、圧縮された徐放性単位投薬形態の調製法およびこうして得られた圧縮単位投薬形態
|
|
IE61651B1
(en)
|
1990-07-04 |
1994-11-16 |
Zambon Spa |
Programmed release oral solid pharmaceutical dosage form
|
|
US5310578A
(en)
|
1990-09-17 |
1994-05-10 |
Merck Patent Gesellschaft |
Deposition of cosmetically functional material onto pigments and fillers
|
|
US5316772A
(en)
|
1990-12-19 |
1994-05-31 |
Solvay & Cie, S.A. (Societe Anonyme) |
Bilayered oral pharmaceutical composition with pH dependent release
|
|
EP0565560B1
(en)
|
1991-01-03 |
1994-09-28 |
Glaxo Canada Inc. |
Method for production of solid pharmaceutical preparation
|
|
DE4100920A1
(de)
*
|
1991-01-15 |
1992-07-16 |
Degussa |
Wirkstoffzubereitung zur oralen verabreichung an wiederkaeuer
|
|
ES2106818T3
(es)
|
1991-10-30 |
1997-11-16 |
Glaxo Group Ltd |
Composicion multicapa que contiene antagonistas de histamina o secotina.
|
|
WO1993019741A1
(en)
|
1992-03-31 |
1993-10-14 |
Benzon Pharma A/S |
A pharmaceutical formulation
|
|
GB9215908D0
(en)
|
1992-07-27 |
1992-09-09 |
Wellcome Found |
Water dispersible tablets
|
|
JPH07507564A
(ja)
|
1992-09-30 |
1995-08-24 |
ファイザー・インク． |
コア及び厚さが一定でないコーティングを含有する物品
|
|
WO1994008589A1
(en)
|
1992-10-09 |
1994-04-28 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment of systemic lupus erythematosus with dehydroepiandrosterone
|
|
TW272942B
(sr)
|
1993-02-10 |
1996-03-21 |
Takeda Pharm Industry Co Ltd |
|
|
DK66493D0
(da)
|
1993-06-08 |
1993-06-08 |
Ferring A S |
Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
|
|
IL110376A
(en)
|
1993-08-02 |
1998-08-16 |
Bristol Myers Squibb Co |
Pharmaceutical preparations containing iftroban and methods for their preparation
|
|
DE4332394A1
(de)
|
1993-09-23 |
1995-03-30 |
Falk Pharma Gmbh |
Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
|
|
US5482718A
(en)
|
1994-03-23 |
1996-01-09 |
Hoffmann-La Roche Inc. |
Colon-targeted delivery system
|
|
US5464633A
(en)
|
1994-05-24 |
1995-11-07 |
Jagotec Ag |
Pharmaceutical tablets releasing the active substance after a definite period of time
|
|
US5702723A
(en)
|
1994-08-02 |
1997-12-30 |
Griffin; David |
Multi-stage delivery system for ingestible medications or nutrients
|
|
US5811388A
(en)
|
1995-06-07 |
1998-09-22 |
Cibus Pharmaceutical, Inc. |
Delivery of drugs to the lower GI tract
|
|
US5709880A
(en)
|
1995-07-10 |
1998-01-20 |
Buckman Laboratories International, Inc. |
Method of making tabletized ionene polymers
|
|
IT1276031B1
(it)
|
1995-10-31 |
1997-10-24 |
Angelini Ricerche Spa |
Composizione farmaceutica per il trattamento delle malattie autoimmuni
|
|
JP3220373B2
(ja)
|
1995-11-28 |
2001-10-22 |
バイエル薬品株式会社 |
持続性ニフエジピン製剤
|
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
US5840332A
(en)
|
1996-01-18 |
1998-11-24 |
Perio Products Ltd. |
Gastrointestinal drug delivery system
|
|
AU1751997A
(en)
|
1996-01-30 |
1997-08-22 |
Advanced Polymer Systems Inc. |
Targeted delivery of drugs to the lower gastrointestinal tract
|
|
IT1282576B1
(it)
|
1996-02-06 |
1998-03-31 |
Jagotec Ag |
Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
|
|
HRP970493A2
(en)
|
1996-09-23 |
1998-08-31 |
Wienman E. Phlips |
Oral delayed immediate release medical formulation and method for preparing the same
|
|
US6190591B1
(en)
|
1996-10-28 |
2001-02-20 |
General Mills, Inc. |
Embedding and encapsulation of controlled release particles
|
|
US5792476A
(en)
*
|
1996-12-19 |
1998-08-11 |
Abigo Medical Ab |
Sustained release glucocorticoid pharmaceutical composition
|
|
US5788987A
(en)
*
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
|
US6210710B1
(en)
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
|
EA002482B1
(ru)
|
1997-07-01 |
2002-06-27 |
Пфайзер Инк. |
Соли сертралина и лекарственные формы с длительным высвобождением сертралина
|
|
US6013280A
(en)
|
1997-10-07 |
2000-01-11 |
Fuisz Technologies Ltd. |
Immediate release dosage forms containing microspheres
|
|
AU740757B2
(en)
|
1997-10-09 |
2001-11-15 |
Perio Products Ltd. |
Delayed total release gastrointestinal drug delivery system
|
|
US7201923B1
(en)
|
1998-03-23 |
2007-04-10 |
General Mills, Inc. |
Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
|
|
US6365185B1
(en)
*
|
1998-03-26 |
2002-04-02 |
University Of Cincinnati |
Self-destructing, controlled release peroral drug delivery system
|
|
ATE267589T1
(de)
|
1998-04-03 |
2004-06-15 |
Egalet As |
Zusammensetzung mit kontrollierter wirkstoff- freisetzung
|
|
US6602521B1
(en)
|
1998-09-29 |
2003-08-05 |
Impax Pharmaceuticals, Inc. |
Multiplex drug delivery system suitable for oral administration
|
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
|
DE60042352D1
(de)
|
1999-02-10 |
2009-07-23 |
Pfizer Prod Inc |
Osmotisches System zur Verabreichung von Wirkstoffen, die feste amorphe Dispersionen enthalten
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
|
GB9905898D0
(en)
*
|
1999-03-15 |
1999-05-05 |
Darwin Discovery Ltd |
Controlled-dose formulation
|
|
US6677326B2
(en)
|
1999-03-15 |
2004-01-13 |
Arakis, Ltd. |
Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration
|
|
US6245352B1
(en)
|
1999-04-27 |
2001-06-12 |
Eli Lilly And Company |
Pharmaceutical formulation
|
|
JP2001010950A
(ja)
|
1999-06-29 |
2001-01-16 |
Taiyo Yakuhin Kogyo Kk |
安定で良好な薬物放出を有する医薬組成物
|
|
US6458383B2
(en)
|
1999-08-17 |
2002-10-01 |
Lipocine, Inc. |
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
US6500459B1
(en)
|
1999-07-21 |
2002-12-31 |
Harinderpal Chhabra |
Controlled onset and sustained release dosage forms and the preparation thereof
|
|
EP1074249A1
(en)
|
1999-07-27 |
2001-02-07 |
Jagotec Ag |
A pharmaceutical tablet system for releasing at least one active substance during a release period subsequent to a no-release period
|
|
US6428809B1
(en)
|
1999-08-18 |
2002-08-06 |
Microdose Technologies, Inc. |
Metering and packaging of controlled release medication
|
|
AR026148A1
(es)
|
2000-01-21 |
2003-01-29 |
Osmotica Argentina S A |
Dispositivo osmotico con pasaje preformado que aumenta de tamano
|
|
DE10012555A1
(de)
|
2000-03-15 |
2001-09-20 |
Merck Patent Gmbh |
Glucocorticoide in einer Modified Release-Formulierung
|
|
DE10014588A1
(de)
|
2000-03-27 |
2001-10-04 |
Basf Ag |
Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
|
|
DE10015479A1
(de)
|
2000-03-29 |
2001-10-11 |
Basf Ag |
Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
|
|
US20020028240A1
(en)
|
2000-04-17 |
2002-03-07 |
Toyohiro Sawada |
Timed-release compression-coated solid composition for oral administration
|
|
WO2001080824A2
(en)
|
2000-04-19 |
2001-11-01 |
Eurand America, Inc. |
Dual mechanism timed release dosage forms for low dose drugs
|
|
DE10029201A1
(de)
|
2000-06-19 |
2001-12-20 |
Basf Ag |
Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
|
|
US6476006B2
(en)
|
2000-06-23 |
2002-11-05 |
Teva Pharmaceutical Industries, Ltd. |
Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
|
|
US6720005B1
(en)
|
2000-07-07 |
2004-04-13 |
The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University |
Coated, platform-generating tablet
|
|
US6620439B1
(en)
|
2000-10-03 |
2003-09-16 |
Atul M. Mehta |
Chrono delivery formulations and method of use thereof
|
|
US6589562B1
(en)
|
2000-10-25 |
2003-07-08 |
Salvona L.L.C. |
Multicomponent biodegradable bioadhesive controlled release system for oral care products
|
|
US6887493B2
(en)
|
2000-10-25 |
2005-05-03 |
Adi Shefer |
Multi component controlled release system for oral care, food products, nutraceutical, and beverages
|
|
US6565873B1
(en)
|
2000-10-25 |
2003-05-20 |
Salvona Llc |
Biodegradable bioadhesive controlled release system of nano-particles for oral care products
|
|
CA2440641A1
(en)
|
2001-03-13 |
2002-09-19 |
Anand R. Baichwal |
Chronotherapeutic dosage forms containing glucocorticosteroid
|
|
ATE477804T1
(de)
|
2001-03-15 |
2010-09-15 |
Soligenix Inc |
Verfahren zur behandlung von entzündlichen erkrankungen des verdauungstrakts mit topisch wirksamen kortikosteroiden
|
|
IN191028B
(sr)
|
2001-05-17 |
2003-09-13 |
Sun Pharmaceutical Ind Ltd |
|
|
US20030021841A1
(en)
|
2001-07-02 |
2003-01-30 |
Matharu Amol Singh |
Pharmaceutical composition
|
|
WO2003011255A1
(en)
|
2001-07-04 |
2003-02-13 |
Sun Pharmaceutical Industries Limited |
Gastric retention controlled drug delivery system
|
|
WO2003011254A1
(en)
|
2001-07-31 |
2003-02-13 |
Capricorn Pharma Inc. |
Amorphous drug beads
|
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
EP1429739A1
(en)
|
2001-09-21 |
2004-06-23 |
Egalet A/S |
Polymer release system
|
|
EP1429744A1
(en)
|
2001-09-21 |
2004-06-23 |
Egalet A/S |
Morphine polymer release system
|
|
HUP0401686A3
(en)
|
2001-09-28 |
2008-04-28 |
Mcneil Ppc Inc |
Dosage forms having an inner core and outer shell with different shapes
|
|
EP1443912B1
(en)
|
2001-10-12 |
2007-08-29 |
Elan Pharma International Limited |
Compositions having a combination of immediate release and controlled release characteristics
|
|
US20080145438A1
(en)
|
2001-12-20 |
2008-06-19 |
Beuford Arlie Bogue |
Micro- and nano-particulate drugs and methods of making thereof
|
|
WO2003061626A1
(en)
|
2002-01-18 |
2003-07-31 |
Control Delivery Systems, Inc. |
Polymeric gel system for the controlled delivery of codrugs
|
|
AU2003208761A1
(en)
|
2002-02-21 |
2003-09-09 |
Amarin Development Ab |
A method for releasing nanosized particles of an active substance from a diffusion-controlled pharmaceutical composition for oral use
|
|
AU2003213338A1
(en)
|
2002-03-14 |
2003-09-22 |
Daiichi Suntory Pharma Co., Ltd. |
Tablet containing pilsicainide hydrochloride (dry)
|
|
EP1490030B2
(en)
|
2002-03-20 |
2010-07-14 |
Elan Pharma International Limited |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
US7074426B2
(en)
|
2002-03-27 |
2006-07-11 |
Frank Kochinke |
Methods and drug delivery systems for the treatment of orofacial diseases
|
|
US7985422B2
(en)
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
|
US20040062778A1
(en)
|
2002-09-26 |
2004-04-01 |
Adi Shefer |
Surface dissolution and/or bulk erosion controlled release compositions and devices
|
|
WO2004028512A1
(en)
|
2002-09-28 |
2004-04-08 |
Mcneil-Ppc, Inc. |
Modified release dosage form with two cores
|
|
US20080220074A1
(en)
|
2002-10-04 |
2008-09-11 |
Elan Corporation Plc |
Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
|
|
US20040121010A1
(en)
*
|
2002-10-25 |
2004-06-24 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
|
US7704527B2
(en)
|
2002-10-25 |
2010-04-27 |
Collegium Pharmaceutical, Inc. |
Modified release compositions of milnacipran
|
|
ES2365012T3
(es)
|
2002-11-12 |
2011-09-20 |
Elan Pharma International Limited |
Formas farmacéuticas sólidas de desintegración rápida que no son friables y que comprenden pululano.
|
|
US20040185097A1
(en)
|
2003-01-31 |
2004-09-23 |
Glenmark Pharmaceuticals Ltd. |
Controlled release modifying complex and pharmaceutical compositions thereof
|
|
PL1631251T3
(pl)
|
2003-04-24 |
2011-12-30 |
Jagotec Ag |
Tabletka o opóźnionym uwalnianiu i o określonej geometrii
|
|
EP1615626B1
(en)
|
2003-04-24 |
2009-10-14 |
Jagotec Ag |
Tablet with coloured core
|
|
US8029822B2
(en)
|
2003-05-22 |
2011-10-04 |
Osmotica Kereskedelmi és Seolgáltató KFT |
Rupturing controlled release device having a preformed passageway
|
|
UY28326A1
(es)
|
2003-05-22 |
2004-06-30 |
Osmotica Argentina S A |
Dispositivo de ruptura de liberacion controlada con un pasaje preformado
|
|
US20060177507A1
(en)
|
2003-05-22 |
2006-08-10 |
Joaquina Faour |
Controlled release device containing lercanidipine
|
|
JP2007001865A
(ja)
|
2003-09-16 |
2007-01-11 |
Ltt Bio-Pharma Co Ltd |
脂溶性薬物封入微粒子、その製造法およびそれを含有する製剤
|
|
WO2005027843A2
(en)
|
2003-09-19 |
2005-03-31 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms
|
|
DE102004035936A1
(de)
|
2004-07-23 |
2006-03-16 |
Röhm GmbH & Co. KG |
Mehrschichtige Arzneiform
|
|
DE102004043863A1
(de)
|
2004-09-10 |
2006-03-16 |
Nitec Pharma Ag |
Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
|
|
JP5134955B2
(ja)
*
|
2004-09-10 |
2013-01-30 |
ヤゴテック アクチエンゲゼルシャフト |
活性成分の部位時間制御胃腸放出作用を有する錠剤
|
|
GB0427455D0
(en)
|
2004-12-15 |
2005-01-19 |
Jagotec Ag |
Dosage forms
|
|
EP1861072A2
(en)
|
2005-03-14 |
2007-12-05 |
Massachusetts Institute Of Technology |
Nanocells for diagnosis and treatment of diseases and disorders
|
|
US9149439B2
(en)
|
2005-03-21 |
2015-10-06 |
Sandoz Ag |
Multi-particulate, modified-release composition
|
|
US7241805B2
(en)
|
2005-06-27 |
2007-07-10 |
Biovail Laboratories, Inc. |
Modified release formulations of a bupropion salt
|
|
EP1898886B1
(en)
|
2005-07-01 |
2019-09-04 |
Rubicon Research Pvt Ltd. |
Novel sustained release dosage form
|
|
US20080248107A1
(en)
|
2005-08-24 |
2008-10-09 |
Rubicon Research Pvt. Ltd. |
Controlled Release Formulation
|
|
FR2891459B1
(fr)
|
2005-09-30 |
2007-12-28 |
Flamel Technologies Sa |
Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
|
|
WO2008134071A1
(en)
|
2007-04-26 |
2008-11-06 |
Theraquest Biosciences, Inc. |
Multimodal abuse resistant extended release formulations
|
|
US8324192B2
(en)
|
2005-11-12 |
2012-12-04 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
WO2007064912A2
(en)
|
2005-12-02 |
2007-06-07 |
Elan Pharma International Limited |
Mometasone compositions and methods of making and using the same
|
|
US20080213374A1
(en)
|
2006-07-10 |
2008-09-04 |
Elan Pharma International Limited |
Nanoparticulate sorafenib formulations
|
|
US20080014272A1
(en)
|
2006-07-11 |
2008-01-17 |
Phil Skolnick |
Compositions and Methods for Treatment of Chronic Pain Conditions
|
|
US20080026040A1
(en)
|
2006-07-31 |
2008-01-31 |
Isaac Farr |
Active agent-releasing dosage forms
|
|
CN101466385B
(zh)
|
2006-08-03 |
2014-01-08 |
耐特克药物股份公司 |
类风湿病的延迟释放糖皮质激素治疗
|
|
CA2660029A1
(en)
|
2006-08-04 |
2008-02-07 |
Nastech Pharmaceutical Company Inc. |
Compositions for intranasal delivery of human insulin and uses thereof
|
|
CL2007002214A1
(es)
|
2006-08-14 |
2008-03-07 |
Boehringer Ingelheim Int |
Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
|
|
JP2010501607A
(ja)
|
2006-08-30 |
2010-01-21 |
ヤゴテック アーゲー |
ニソルジピンを含有する徐放性の固体状経口投与用配合剤
|
|
US20080057086A1
(en)
|
2006-09-01 |
2008-03-06 |
Pharmion Corporation |
Colon-targeted oral formulations of cytidine analogs
|
|
WO2008032212A2
(en)
|
2006-09-08 |
2008-03-20 |
Foamix Ltd. |
Colored or colorable foamable composition and foam
|
|
WO2008033351A2
(en)
|
2006-09-11 |
2008-03-20 |
Theraquest Biosciences, Inc. |
Multimodal abuse resistant and extended release formulations
|
|
EP2097086A4
(en)
|
2006-11-14 |
2012-01-11 |
Yissum Res Dev Co |
CONTACT LENS COMPOSITIONS
|
|
WO2008079963A2
(en)
|
2006-12-22 |
2008-07-03 |
Cambrex Charles City, Inc. |
Pharmaceutical compositions comprising ionic complexes of active pharmaceutical ingredients
|
|
WO2008085484A2
(en)
|
2006-12-28 |
2008-07-17 |
Jacobus Pharmaceutical Company, Inc. |
Treatment of inflammatory bowel disease with enteric coated formulations comprising 5-aminosalicylic acid or 4-aminosalicylic acid
|
|
GB2445539A
(en)
|
2006-12-29 |
2008-07-16 |
Ardana Bioscience Ltd |
Bigel composition
|
|
US20080181932A1
(en)
|
2007-01-30 |
2008-07-31 |
Drugtech Corporation |
Compositions for oral delivery of pharmaceuticals
|
|
WO2008104996A2
(en)
|
2007-02-28 |
2008-09-04 |
Jubilant Organosys Limited |
Water dispersible pharmaceutical formulation and process for preparing the same
|
|
EP2146696B1
(en)
|
2007-04-13 |
2020-01-22 |
Dow Global Technologies LLC |
Granular material for dosage forms
|
|
KR101506607B1
(ko)
|
2007-04-13 |
2015-03-30 |
켐제닉스 파마슈티칼스 인크. |
세팔로탁신 경구 제형
|
|
WO2008140459A1
(en)
|
2007-05-16 |
2008-11-20 |
Fmc Corporation |
Solid form
|
|
US20080311162A1
(en)
|
2007-05-16 |
2008-12-18 |
Olivia Darmuzey |
Solid form
|
|
WO2008140460A1
(en)
|
2007-05-16 |
2008-11-20 |
Fmc Corporation |
Solid form
|
|
US20080286343A1
(en)
|
2007-05-16 |
2008-11-20 |
Dzenana Cengic |
Solid form
|
|
SI2167033T1
(sl)
|
2007-05-30 |
2017-08-31 |
Veloxis Pharmaceuticals A/S |
Odmerna oblika, ki obsega takrolimus, za dajanje enkrat na dan
|
|
CA2687192C
(en)
|
2007-06-04 |
2015-11-24 |
Egalet A/S |
Controlled release pharmaceutical compositions for prolonged effect
|
|
EP2008651A1
(en)
|
2007-06-26 |
2008-12-31 |
Drug Delivery Solutions Limited |
A bioerodible patch
|
|
RU2010109408A
(ru)
|
2007-08-13 |
2011-09-20 |
Панацея Биотек Лимитед (In) |
Композиции с пролонгированным высвобождением, включающие микофенолят натрия, и их действия
|
|
EP2203056A1
(en)
|
2007-09-25 |
2010-07-07 |
Nirmal Mulye |
Controlled release pharmaceutical compositions
|
|
HUE043897T2
(hu)
|
2007-09-25 |
2019-09-30 |
Solubest Ltd |
Lipofil hatóanyagot tartalmazó készítmények és eljárás elõállításukra
|
|
AR068745A1
(es)
|
2007-10-08 |
2009-12-02 |
Panacea Biotec Ltd |
Una composicion en forma de dosificacion farmaceutica oral de unidad de alta dosis de micofenolato sodico, metodo para utilizar dicha composicion y sus usos
|
|
JP2011500553A
(ja)
|
2007-10-10 |
2011-01-06 |
ルピン・リミテッド |
５−アミノサリチル酸またはその塩もしくは代謝産物の新規な結腸を標的とする調節放出性生体接着性製剤
|
|
US20090123390A1
(en)
|
2007-11-13 |
2009-05-14 |
Meritage Pharma, Inc. |
Compositions for the treatment of gastrointestinal inflammation
|
|
EP2242844A2
(en)
|
2007-12-21 |
2010-10-27 |
Coda Therapeutics, Inc. |
Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions
|
|
AU2008343756A1
(en)
|
2007-12-21 |
2009-07-09 |
Coda Therapeutics, Inc. |
Use of anti-connexin polypeptide agent in combination with anti-connexin polynucleotide agent for the treatment of fibrotic conditions
|
|
AU2008343755A1
(en)
|
2007-12-21 |
2009-07-09 |
Coda Therapeutics, Inc. |
Use of anti-connexin polynucleotides and peptides for the treatment ofabnormal or excessive scars
|
|
KR20100126465A
(ko)
|
2008-03-05 |
2010-12-01 |
파나세아 바이오테크 리미티드 |
미코페놀레이트를 포함하는 변형 방출 제약 조성물 및 그것의 방법
|
|
US8648119B2
(en)
|
2008-05-23 |
2014-02-11 |
Otonomy, Inc. |
Controlled release immunomodulator compositions and methods for the treatment of otic disorders
|
|
WO2009142772A2
(en)
|
2008-05-23 |
2009-11-26 |
Mastcell Pharmaceuticals, Inc. |
Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
|
|
WO2009152479A1
(en)
|
2008-06-12 |
2009-12-17 |
University Of Alabama Huntsville |
Compositions comprising nitric oxide or nitric oxide donors for the treatment of neurodegenerative diseases of trauma
|
|
GB2462022B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
|
|
CL2009001884A1
(es)
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
|
TWI494108B
(zh)
|
2009-01-26 |
2015-08-01 |
Nitec Pharma Ag |
糖皮質激素用以製備嚴重夜間氣喘用之於延遲釋放型的藥物之用途
|
|
NZ582836A
(en)
|
2009-01-30 |
2011-06-30 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
|